Special Issue on Metabolism and Metabolite Markers in Type 2 Diabetes

[...]emerging dual receptor agonists, in particular targeting GIP together with GLP-1 receptors, appear very promising. Besides glucose control, obviously other cardiometabolic risk factors need to be addressed, including hypertension, dyslipidemia, central obesity, and smoking. Pharmacological mechanisms involved in type 2 diabetes development are also discussed. [...]there is a study on HMG-CoA reductase activity, cholesterol levels, and the diabetogenic effect of statin treatment. [...]another review paper elucidates the mechanisms of physical activity to reverse insulin resistance.